Broker says buy the dip on ASX 200 uranium share with 69% upside

Shaw and Partners says this ASX uranium stock is trading at an attractive price point right now.

| More on:
A miner stands in front oh an excavator at a mine site

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX 200 uranium share Paladin Energy Ltd (ASX: PDN) sure has exhibited some volatility this year.

Take a look at this chart below.

Paladin Energy shares had a phenomenal run over the 12 months to May this year.

The ASX 200 uranium share soared by 159% to a 52-week peak of $17.98 apiece on 22 May.

Since then, the stock has tumbled on a fluctuating but overall downward path.

Paladin shares hit a new 52-week low of $8.15 on 9 September.

They quickly recovered to trade above $13 per share last month, then began falling again.

The stock is now trading at $9.49 on Tuesday, down 3.4% for the day so far.

So, should you buy the latest dip?

Broker Shaw and Partners has released a note explaining their view.

Time to buy the dip on this ASX 200 uranium share?

Last week, Paladin Energy released its September quarter activities report and cash flow report.

Shaw and Partners described it as a "disappointing" quarter due to commissioning issues at the Langer Heinrich uranium mine in Namibia.

On the day the reports were released, the Paladin Energy share price fell by more than 15%.

Shaw and Partners saw this as an "over-reaction".

According to the note:

It was a disappointing quarter due to commissioning issues at Langer Heinrich.

However, none of the issues appear to be more than run-of-the-mill commissioning issues, and a 15% pullback in the share price is an over-reaction.

Nonetheless, we have downgraded our FY25 EBITDA forecast by 11% as a result of lower assumed production. We have not changed FY26+ forecasts.

We retain our BUY recommendation and view today's pullback as another entry point to what is likely to be a multi-year uranium up-cycle.

Shaw and Partners trimmed its 12-month share price target on Paladin Energy from $16.80 to $16. 

Based on today's share price, this implies a potential upside of 69%.

Shaw and Partners isn't the only broker that is bullish on this ASX 200 uranium share.

Another broker also bullish on Paladin Energy shares

As my colleague James reports, Bell Potter also sees Paladin's recent share price weakness as an opportunity.

 Bell Potter said:

PDN has announced its intention to acquire Athabasca developer, Fission Uranium in an all-scrip deal.

We see this transaction as transformative for PDN, with the potential to make the business a leader in uranium production across two sites and thus alleviating our concerns around future growth.

With the recent pull-back in the stock we see this as an opportunity to gain exposure to a high-quality uranium producer.

Bell Potter has a buy rating on the ASX 200 uranium share and a 12-month target price of $14.40.

This implies a potential upside of 52% for investors who buy Paladin shares today.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Bell Potter says these ASX stocks are top buys

Let's see why the broker is feeling so bullish on these names.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Buy this ASX All Ords stock for huge returns and a great dividend yield

Bell Potter thinks this buy-rated stock could deliver the goods for investors over the next 12 months.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

Top broker says these ASX stocks can rise 35% in a year

Let's see why Bell Potter thinks these shares could rise strongly over the next 12 months.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

These ASX shares could rise 20% to 50%

Analysts are tipping these shares to rise strongly over the next 12 months.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Broker Notes

7 ASX All Ords shares elevated to 'strong buy' status in October

The brokers turned bullish on these ASX companies last month.

Read more »